Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.

Olsen B, Pham TL, Golparian D, Johansson E, Tran HK, Unemo M.

BMC Infect Dis. 2013 Jan 25;13:40. doi: 10.1186/1471-2334-13-40.

2.
3.

Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union.

Unemo M, Ison CA, Cole M, Spiteri G, van de Laar M, Khotenashvili L.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv42-6. doi: 10.1136/sextrans-2012-050909. Review.

PMID:
24243879
4.

Global resistance of Neisseria gonorrhoeae: when theory becomes reality.

Lewis DA.

Curr Opin Infect Dis. 2014 Feb;27(1):62-7. doi: 10.1097/QCO.0000000000000025. Review.

PMID:
24275696
5.
6.

Gonococcal antimicrobial resistance in the Western Pacific Region.

Lahra MM, Lo YR, Whiley DM.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv19-23. doi: 10.1136/sextrans-2012-050906. Review.

PMID:
24243875
7.

Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Unemo M, Nicholas RA.

Future Microbiol. 2012 Dec;7(12):1401-22. doi: 10.2217/fmb.12.117. Review.

8.

Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Unemo M, Shafer WM.

Clin Microbiol Rev. 2014 Jul;27(3):587-613. doi: 10.1128/CMR.00010-14. Review.

9.

The use of cephalosporins for gonorrhea: the impending problem of resistance.

Barry PM, Klausner JD.

Expert Opin Pharmacother. 2009 Mar;10(4):555-77. doi: 10.1517/14656560902731993 . Review.

10.

Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?

Lewis DA.

Sex Transm Infect. 2015 Jun;91(4):234-7. doi: 10.1136/sextrans-2014-051731. Epub 2015 Apr 24. Review.

PMID:
25911525
11.

Current and future treatment options for gonorrhoea.

Ison CA, Deal C, Unemo M.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv52-6. doi: 10.1136/sextrans-2012-050913. Epub 2013 Oct 8. Review.

PMID:
24106339
12.

Preparing for an era of untreatable gonorrhea.

Barbee LA.

Curr Opin Infect Dis. 2014 Jun;27(3):282-7. doi: 10.1097/QCO.0000000000000058. Review.

13.

The role of core groups in the emergence and dissemination of antimicrobial-resistant N gonorrhoeae.

Lewis DA.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv47-51. doi: 10.1136/sextrans-2013-051020. Review. Erratum in: Sex Transm Infect. 2014 Aug;90(5):400.

PMID:
24243880
14.

Stemming the tide of drug-resistant Neisseria gonorrhoeae: the need for an individualized approach to treatment.

Buono SA, Watson TD, Borenstein LA, Klausner JD, Pandori MW, Godwin HA.

J Antimicrob Chemother. 2015 Feb;70(2):374-81. doi: 10.1093/jac/dku396. Epub 2014 Oct 19. Review.

15.

Gonococcal antimicrobial resistance: perspectives from the African region.

Ndowa FJ, Francis JM, Machiha A, Faye-Kette H, Fonkoua MC.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv11-5. doi: 10.1136/sextrans-2012-050907. Review.

PMID:
24243873
16.

Worldwide susceptibility rates of Neisseria gonorrhoeae isolates to cefixime and cefpodoxime: a systematic review and meta-analysis.

Yu RX, Yin Y, Wang GQ, Chen SC, Zheng BJ, Dai XQ, Han Y, Li Q, Zhang GY, Chen X.

PLoS One. 2014 Jan 31;9(1):e87849. doi: 10.1371/journal.pone.0087849. eCollection 2014. Review.

17.

Frequency and correlates of culture-positive infection with Neisseria gonorrhoeae in England: a review of sentinel surveillance data.

Mohammed H, Ison CA, Obi C, Chisholm S, Cole M, Quaye N, Hughes G; GRASP Collaborative Group.

Sex Transm Infect. 2015 Jun;91(4):287-93. doi: 10.1136/sextrans-2014-051756. Epub 2014 Oct 28. Review.

PMID:
25352692
18.

Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea.

Low N, Unemo M, Skov Jensen J, Breuer J, Stephenson JM.

PLoS Med. 2014 Feb 4;11(2):e1001598. doi: 10.1371/journal.pmed.1001598. eCollection 2014 Feb. Review. No abstract available.

19.

Moving forward in tackling antimicrobial resistance: WHO actions.

Lusti-Narasimhan M, Pessoa-Silva CL, Temmerman M.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv57-9. doi: 10.1136/sextrans-2012-050910. Epub 2013 Nov 7. Review.

PMID:
24202206
20.

Evolving gonococcal antimicrobial resistance: research priorities and implications for management.

Hook EW, Van Der Pol B.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv60-2. doi: 10.1136/sextrans-2013-051021. Review.

PMID:
24243882
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk